CTH and glioblastoma: Because of our findings that invasive GBM cells exhibit metabolomic, lipidomic, and transcriptomic changes protecting against ferroptosis (Figure 1D, Figure 2E, and Figure 3D), we then investigated whether cysteine supplementation or CTH targeting affected the sensitivity of GBM cells in 2D culture to the ferroptosis inducer erastin.